Group 1 - The brain-computer interface (BCI) sector is experiencing active performance, with companies like Aipeng Medical and Innovation Medical seeing significant stock increases, indicating a potential explosive growth phase for the industry [1] - A research team led by Professor Jin Jing from East China University of Science and Technology has developed a new mixed-reality enhanced BCI system for quadruped control, which integrates mixed reality technology with BCI for efficient and stable control of robotic dogs [1][2] - The traditional BCI systems face challenges in real-world applications, such as environmental light interference and poor portability, which limit their performance and application range. The new framework proposed by Jin's team aims to enhance BCI systems with features like anti-interference, high performance, and portability [1] Group 2 - The rapid development of BCI technology is supported by advancements in artificial intelligence, neuroscience, and sensors, with China's "14th Five-Year Plan" designating "brain science and brain-like research" as a key frontier technology project [2] - The global market for BCI technology is projected to reach $1.98 billion in 2023 and exceed $6 billion by 2028, with a compound annual growth rate of 25.22% over five years [2] - China is making significant strides in non-invasive BCI technology, with policies supporting the industry and a goal to achieve core technology autonomy and clinical application by 2030 [2][3] Group 3 - The BCI industry is witnessing breakthroughs in applications such as motor recovery, language communication, and hearing restoration, driven by technological advancements and supportive national policies [3] - Recent policy initiatives, including the National Medical Insurance Administration's decision to separately list new BCI technology pricing, are paving the way for clinical application and service charge pathways [3] - Domestic BCI companies are expected to gradually achieve commercialization due to technological innovations and policy incentives [3]
脑机概念股表现活跃,爱朋医疗等多股走高,机构称行业正式进入爆发式增长阶段